05/04/2026
🫀 SPIRIT-HF at : Spironolactone, an aldosterone blocker, compared with placebo, did not show any significant improvement in terms of HF hospitalizations and cardiovascular death at 24 months in patients with or .
See the results ➡️ https://bit.ly/4cbiPeW